Emla and Zits - a phase IV clinical study of FDA data

Summary:

Zits is found among people who take Emla, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Emla and have Zits. It is created by eHealthMe based on reports of 4,645 people who have side effects when taking Emla from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 10, 2023

4,645 people reported to have side effects when taking Emla.
Among them, 11 people (0.24%) have Zits.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.

What is Zits?

Zits (pimple/small skin inflammations or lesions/acne) is found to be associated with 2,794 drugs and 2,232 conditions by eHealthMe.

Number of Emla and Zits reports submitted per year:

Gender of people who have Zits when taking Emla *:

female: 90.91 %
male: 9.09 %

Age of people who have Zits when taking Emla *:

Common drugs people take besides Emla *:

Common side effects people have besides Zits *:

Back Pain: 11 people, 100.00%
Neck Pain: 11 people, 100.00%
Head Injury: 10 people, 90.91%
Fall: 10 people, 90.91%
Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 90.91%
Fluid Retention (an abnormal accumulation of fluid in the blood): 10 people, 90.91%
Fractured Sacrum: 10 people, 90.91%
Gastric Polyps (abnormal growth of stomach tissue projecting from a mucous membrane): 10 people, 90.91%
Gastritis (inflammation of stomach): 10 people, 90.91%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 90.91%

Common conditions people have *:

Metastases To Bone (cancer spreads to bone): 10 people, 90.91%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Emla and have Zits?

Check whether Zits is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Zits and when was it recovered:

Zits in Emla

Expand to all the drugs that have ingredients of lidocaine; prilocaine:

Zits and drugs with ingredients of lidocaine; prilocaine

Alternative drugs to, pros and cons of Emla:

Emla (4,653 reports)

Common Emla side effects:

Fatigue (feeling of tiredness): 477 reports
Diarrhea: 344 reports
Nausea and vomiting: 297 reports
Fever: 287 reports
Headache (pain in head): 283 reports
Weakness: 281 reports
Rashes (redness): 263 reports
Breathing difficulty: 257 reports

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Zits treatments and more:

Zits (164,861 reports)

COVID vaccines that are related to Zits:

Common drugs associated with Zits:

All the drugs that are associated with Zits:

Zits (2,794 drugs)

Common conditions associated with Zits:

Acne: 25,066 reports
Birth control: 2,621 reports
Rheumatoid arthritis: 2,294 reports
Crohn's disease: 1,440 reports
Multiple sclerosis: 1,113 reports

All the conditions that are associated with Zits:

Zits (2,232 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.